ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 48 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2017. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |